SPHD — INVESCO EXCH TRADED FD TR II

Ownership history in Prostatis Group LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Prostatis Group LLC reported a position in INVESCO EXCH TRADED FD TR II (SPHD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.54% (2025 Q1)
Avg. % of fund
1.21%
First filed
2023 Q1
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 95,525 +1,275 +1.4% 1.09% $4.6M $47.61
2025 Q3 ADDED 94,250 +85,887 +1027.0% 1.17% $4.7M $48.46
2025 Q2 REDUCED 8,363 -152,212 -94.8% 0.11% $398K $46.13
2025 Q1 ADDED 160,575 +115,423 +255.6% 2.54% $8.1M $48.28
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SPHD price (monthly, adj. close)

Other funds also holding SPHD

As of 2025 Q4 — sorted by position size

BTS Asset Management, Inc. 3Y 7Y 11.77% Delos Wealth Advisors, LLC 3Y 2.36% Advocate Investing Services LLC 2.06% Fusion Capital, LLC 3Y 1.72% Portland Financial Advisors Inc 1.49% Pinnacle Wealth Management Group, Inc. 3Y 1.39% Foguth Wealth Management, LLC. 1.39% TLS Advisors LLC 3Y 1.21% Leelyn Smith, LLC 3Y 1.17% Lynx Investment Advisory 1.16%
← Back to Prostatis Group LLC Holdings